Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Strengths include clarity and control, while weaknesses may involve complexity and time to maintain across life changes.
28,655 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Zenith Labs announced a new cross-chain bridge that lets the Canton network and Ethereum swap tokens via atomic swaps...
Revolut launches its first physical crypto card, letting users spend digital assets in daily purchases as it rolls ou...
Two Harbors Investment Corp. delayed its stockholder meeting again as votes on the CrossCountry Mortgage affiliate sa...
Circle debuted CirBTC on Ethereum, a 1:1 BTC-backed ERC-20 token with real-time reserve proof, targeting institutiona...
SoFi faces a fragile mix of improving profitability and credit risk as growth opportunities widen. This analysis weig...
A new look at college pricing shows that the real reason college costs stay high isn’t tuition alone. Living costs an...
MicroStrategy remains tethered to Bitcoin moves, but bullish bets persist as the company expands its digital-asset st...
A new science council linked to Trump signals a stronger link between AI and crypto policy. This morning minute exami...
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
Sprott just bought a large stake in its own stock. What does this mean for investors? This guide breaks down the impl...